The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.

Commons, RJ; Simpson, JA; Thriemer, K; Humphreys, GS; Abreha, T; Alemu, SG; Añez, A; Anstey, NM; Awab, GR; Baird, JK; +44 more... Barber, BE; Borghini-Fuhrer, I; Chu, CS; D'Alessandro, U; Dahal, P; Daher, A; de Vries, PJ; Erhart, A; Gomes, MSM; Gonzalez-Ceron, L; Grigg, MJ; Heidari, A; Hwang, J; Kager, PA; Ketema, T; Khan, WA; Lacerda, MVG; Leslie, T; Ley, B; Lidia, K; Monteiro, WM; Nosten, F; Pereira, DB; Phan, GT; Phyo, AP; Rowland, M; Saravu, K; Sibley, CH; Siqueira, AM; Stepniewska, K; Sutanto, I; Taylor, WRJ; Thwaites, G; Tran, BQ; Tran, HT; Valecha, N; Vieira, JLF; Wangchuk, S; William, T; Woodrow, CJ; Zuluaga-Idarraga, L; Guerin, PJ; White, NJ; Price, RN; (2018) The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. The Lancet infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(18)30348-7

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(18)30348-7

Abstract

Share

Download

Filename: The effect of chloroquine dose_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar